BioSpace News Archive

Amyris, Inc., a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, announced that it has priced $600.0 million aggregate principal amount of 1.50% convertible senior notes due 2026.

Aridis Pharmaceuticals, Inc. today reported financial and corporate results for its third quarter ended September 30, 2021.

Endologix LLC announced today the appointment of Dr. Matthew Thompson, as President and Chief Executive Officer.

Virpax® Pharmaceuticals, Inc. announced that the National Center for Advancing Translational Sciences at the National Institutes of Health has awarded research and development contracts to support Good Manufacturing Practices production of drug substance and drug product.

Axcella Therapeutics today announced financial results for the third quarter ended September 30, 2021 and provided a business update.

PhaseBio Pharmaceuticals, Inc. today announced that it will host an investor call on November 15, 2021, at 12:30 p.m. ET

Pharvaris Reports Third Quarter 2021 Financial Results and Provides Business Highlights

Secarna Pharmaceuticals GmbH & Co. KG today announced that the Company has entered into a research, option and license agreement with Achilles Therapeutics UK Limited (“Achilles”), a member of the Achilles Therapeutics plc (NASDAQ:ACHL) group of companies, in the field of immune oncology.

Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced the formation of the Boston Epigenetics Society; a Society who will meet four times a year with the goal of promoting epigenetics and epitranscriptomics research, fostering connections between academics and industry epigenetics scientists, promoting new methods, and creating a support system for experimental epigenetics research.

Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus -based gene therapies for the treatment of rare inherited retinal diseases, announced that Sue Washer, President and Chief Executive Officer of AGTC, will be participating in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17, 2021 at 10:40 a.m. ET.